Atlas FDA

Guidant CONTAK RENEWAL 3 RF (models H210, H215), CONTAK RENEWAL 3 RF HE (models H217, H219) ,CONTAK RENEWAL 4 RF (model

FDA device recall Z-0269-2007 · posted 2006-12-16 · Terminated

Recall details

Recalling firm
Guidant Corporation
Reason for recall
Shock Effectiveness: there is a potential for malfunction of a high voltage wire, which could compromise effectiveness of shock therapy. While no energy is lost, defibrillation thresholds may be higher (and safety margin may be reduced) because the shocking vector has changed.
Action taken
An Important Medical Device Information letter, dated 10/09/2006 was sent to physicians following patients with a potentially affected device. The letter describes the issue, provides for a projected rate of occurrence, and provides recommendations. An October 9, 2006 Product Advisory Letter, beginning October 30, 2006, was also sent to provide an update that further laboratory testing and analysis indicates that the nominal probability of malfunction is higher than their earlier prediction. Non-implanted devices have been retrieved.
Root cause
Other
Status
Terminated
Product code
LWP
Quantity affected
57 (46-USA, 11 Foreign- Renewal 4RF)
Distribution
Worldwide distribution ---- including states of CA, FL, GA, IA, IL, KY, MA, MO, NJ, NY, OH, PA, TX and countries of Italy, Netherlands, Sweden, United Kingdom.
Date initiated
2006-09-30
Date posted
2006-12-16
Date terminated
2007-04-01
Location
Saint Paul, MN

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.